Cargando…
In silico evidence of Remdesivir action in blood coagulation cascade modulation in COVID-19 treatment
BACKGROUND: Coronavirus disease 2019 (COVID-19) has demonstrated several clinical manifestations which include not only respiratory system issues but also liver, kidney, and other organ injuries. One of these abnormalities is coagulopathies, including thrombosis and disseminated intravascular coagul...
Autores principales: | Pagliarin, Luis Gustavo, de Oliveira, Lucca Miketen, dos Anjos, Valentina Nunes Fontoura, de Souza, Cristiano de Bem Torquato, Peiter, Gabrielle Caroline, Façanha Wendel, Cinthia, Dillmann Groto, Anderson, Freire de Melo, Fabrício, Teixeira, Kádima Nayara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401403/ https://www.ncbi.nlm.nih.gov/pubmed/37547340 http://dx.doi.org/10.4331/wjbc.v14.i4.72 |
Ejemplares similares
-
COVID-19 liver and gastroenterology findings: An in silico analysis of SARS-CoV-2 interactions with liver molecules
por: Peiter, Gabrielle Caroline, et al.
Publicado: (2022) -
Temporal pattern of humoral immune response in mild cases of COVID-19
por: Pilati Campos, Isadora Maria, et al.
Publicado: (2023) -
Lafoensia pacari alleviates intestinal damage by modulating cyclooxygenase-2: In silico and in vivo evaluation in a colitis model
por: Peiter, Gabrielle Caroline, et al.
Publicado: (2023) -
Role of non-Helicobacter pylori gastric Helicobacters in helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma
por: Lemos, Fabian Fellipe Bueno, et al.
Publicado: (2023) -
Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development
por: da Mota, Vítor Hugo Sales, et al.
Publicado: (2022)